FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
U.S. Food and Drug Administration
Feb 27, 2021
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) allowing the Janssen COVID-19 vaccine to be distributed in the U.S for use in individuals 18 years of age and older. The third vaccine is administered as a single dose and the authorization of its use expands the availability of vaccines to combat COVID-19.
Access · Infectious diseases · Policy · Vaccination · Wellness, health promotion, and disease prevention